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Abstract: The primary imaging modality for the detection of pul-
monary metastases is computed tomography (CT). Ideally, a helical
CT scan with 3- to 5-mm reconstruction thickness or a volumetric
thin section scanning should be performed within 4 weeks of
pulmonary metastasectomy. A period of observation to see whether
further metastases develop does not seem to allow better patient
selection. If positron emission tomography is available, it may
identify the extrathoracic metastatic sites in 10 to 15% of patients.
Despite helical CT scan, palpation identifies the metastases not
detected by imaging in 20 to 25% of patients and remains the
standard. No data define the optimal interval for follow-up surveil-
lance imaging.
Key Words: Imaging, Pulmonary metastasectomy, Lung metasta-
ses, Pulmonary nodule.
(J Thorac Oncol. 2010;5: S134–S139)
Imaging is a critical part of patient selection for metasta-sectomy and for planning of the procedure. The focus of
this chapter is to address clinical questions with respect to
imaging in patients being considered for metastasectomy.
Whether metastasectomy is of benefit, and in which pa-
tients, is beyond the scope of this chapter. It is assumed
that metastasectomy is justified in appropriately selected
patients, as discussed in other chapters in this series.
Furthermore, it is assumed that the goal of metastasectomy
is to provide potential cure in patients with pulmonary
metatastases, that is, render the patient disease free as far
as can be determined.
In the context of these assumptions, we considered the
following clinical questions as being most clinically relevant
with respect to imaging:
Y What type and protocol of chest computed tomography
scan (CT) should be performed in patients suspected to
have pulmonary metastases?
Y How should the images be reviewed?
Y Are all nodules detected significant?
Y How recently should a CT scan be done before metas-
tasectomy?
Y Is an observation period with serial CT scanning before
metastasectomy beneficial?
Y Should a positron emission tomography (PET) scan be
performed before metastasectomy to diagnose extratho-
racic or intrathoracic metastases?
Y Is helical CT imaging adequate to avoid palpation of the
lung?
Y What interval of follow-up CT scans is necessary?
METHODS
A systematic review was performed according to the
principles outlined in chapter 3. The databases searched,
eligibility, search strategy, synthesis, and funding source
are all as specified in this chapter. The titles of the 736
articles retrieved were reviewed, but only 16 articles were
identified. Therefore, this was supplemented with individ-
ual searches on PubMed using the terms imaging, CT,
Computed tomography, PET, positron emission tomogra-
phy, and follow-up together with metastasectomy and
lung or pulmonary. The results of both searches are sum-
marized in Figure 1. This was supplemented with a manual
search of the reference lists of the identified articles and
reviews.
The process of study evaluation involved a review of
the titles and selectively also the abstracts of articles identi-
fied by the various methods. Any article that seemed to
potentially contain data that pertained to any of the clinical
questions was reviewed in total (78 articles). Any article that
contained relevant data was included (37 articles).
No formal system was used to rate the quality of an
article. No articles were excluded on the basis of quality;
however, the case reports and review articles that provided
only opinions without new data were excluded. A quantita-
tive analysis was performed using a simple, unweighted
average of the reported results. No meta-analysis or quanti-
tative assessment of consistency was done, and no analysis of
publication bias was performed.
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DATA AND RECOMMENDATIONS REGARDING
THE CLINICAL QUESTIONS
What Type and Protocol of Chest CT Scan Should
be Performed in Patients Suspected to Have
Pulmonary Metastases?
There are little direct data to define the optimal type and
protocol of CT scan in patients with pulmonary metastases.
The majority of studies have involved a helical (spiral) CT
scan with 5-mm collimation and 5-mm reconstruction inter-
val (slice thickness), but reconstruction intervals of 3 to 10
mm have been used. There are data that the helical CT scan
detects approximately 20% more nodules than conventional
CT scan.1–3 Thin (4–5mm) slice thickness on reconstruction
results in an approximately 12% increase in the number of
definite nodules detected.4 Until the advent of multidetector
CT, a collimation thickness of 5 mm represented a reasonable
balance between conflicting factors.5 More recently, the
availability of 64, 128, and 256 slice CT has made chest CT
possible using contiguous volumetric (0.5 mm) thin sec-
tions. These sections may then be reconstructed and reviewed
in multiple planes at varying section thickness, using nodule
detection software and reconstruction algorithms.
Based on the available data, a reasonable recommen-
dation as a minimum standard is to perform a helical CT scan
with 3- to 5-mm reconstruction thickness in patients being
evaluated for possible pulmonary metastasectomy. This
seems to be modest relative benefit in most patients, but it
may change with further research. The evidence for this
recommendation comes from well-designed nonrandomized
studies that have focused directly on this issue, with results
being fairly consistent among a limited number of studies.
Where available, technologic advances have induced
many centers to use multislice CT using volumetric thin
section scanning with reconstruction of images for review at
2- to 4-mm thickness. However, currently, there are no data
on the benefit of multidetector CT scan and volumetric thin
section scanning on patients referred for possible pulmonary
metastasectomy.
How Should the Images be Reviewed?
There is evidence that viewing images by scrolling on
a digital monitor as opposed to static images on cut films
significantly improves by approximately 10% the detection of
small pulmonary nodules (5 mm).6,7 There are now multi-
ple different reconstruction and review techniques that have
been studied in an attempt to improve nodule detection, such
as maximum intensity projection and volume rendering. Re-
cent evidence suggests that reviewing the images as maxi-
mum intensity projection sliding thin slabs is the most effec-
tive technique and increases nodule detection. This technique
summates a contiguous volume of sections, with the thick-
ness of the volume chosen by the viewer, and then displays
the objects within that volume that display the greatest
Hounsfield number. This increases the viewer’s ability to
detect nodules within the lung and distinguish them from the
vessels. Data defining the effect of these techniques in pa-
tients considered for metastasectomy are not available.
There has also been extensive work studying computed
added detection (CAD) in an effort to improve nodule detec-
tion. The published reports show that CAD aids in nodule
detection, but most trials have used CAD in combination with
another reader. Trials have compared CAD plus a second
reader with CAD alone or to either a single reader or two
readers. CAD plus a second reader seems most likely to have
the highest sensitivity for nodule detection. Unfortunately,
CAD suffers from a high false-positive rate and slows the
reader. Currently, there are insufficient data to recommend
using CAD in patients before resection.
Are all Nodules Detected Significant?
The advent of improved CT scanners and reconstruc-
tion techniques, while improving nodule detection, has re-
sulted in the detection of large numbers of clinically insig-
nificant pulmonary nodules. The lung cancer screening trials
have confirmed that in smokers, at least, most of the small
nodules (8 mm) are not malignant. Surprisingly, the avail-
able data in patients considered for metastectomy do not
demonstrate a high false-positive rate (these primarily in-
volved single detector helical CT scan). A common problem
is discriminating between subpleural lymph nodes and pul-
monary metastases: subpleural lymph nodes tend to be flatter
rather than spherical, may have polygonal borders, and may
have septa arising from them. Granulomas are often quite
dense. A completely calcified nodule can be reliably assumed
to be benign, unless the patient has osteosarcoma. The dif-
ferentiation of benign versus malignant nodules is generally a
judgment call and usually cannot be made reliably enough to
avoid either biopsy or close follow-up.
How Recently Should a CT Scan be Done Before
Metastasectomy?
No data are available to directly address how recently a
chest CT scan should be performed before a metastasectomy.
Titles found by literature search
N = 1271
Excluded by
title
N = 1135
Abstracts read
N = 136
Excluded by 
Abstract
N 58 = 
Full papers retrieved and read
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after reading
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Papers from 
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other sources
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FIGURE 1. Flow chart of literature search and review and
selection of pertinent studies.
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Limited data suggest that the patients have poor outcomes
after metastasectomy if they have tumor doubling times of
20 to 40 days, and such patients are unlikely to be consid-
ered realistic candidates for metastasectomy.8 The disease-
free interval between the primary tumor resection and the
appearance of the pulmonary metastases may also be used to
estimate the rate of growth and may be used to justify a
longer interval between a CT scan and metastasectomy in
some circumstances.
It seems reasonable to accept a good quality scan
performed within 4 weeks of the planned resection in most
instances, especially if lung palpation is carried out. This
seems to be a reasonable compromise between having up-to-
date information and avoiding unnecessary expenses. This
general suggestion is based on opinion and speculation with
some indirect data, and it should be modified according to the
clinical judgment and characteristics of the patients in ques-
tion (e.g., the tumor doubling time).
Is an Observation Period with Serial CT Scanning
Before Metastasectomy Beneficial?
There are no data demonstrating that waiting for a
period of time before metastasectomy with repeat imaging
allows more optimal selection of patients. The theoretical
argument for a delay is that metastasectomy can be avoided
in patients in whom rapidly progressive or widely dissemi-
nated disease becomes apparent in the interval. No data have
been reported regarding how often this situation actually
occurs, but it seems to be relatively uncommon based on
qualitative clinical experience. A retrospective comparison of
patients who underwent metastasectomy at varying intervals
between detection of the first pulmonary metastasis and
metastasectomy found that the same number developed ad-
ditional subsequent metastases regardless of the interval.9
Furthermore, there was no difference in the proportion of
patients in whom a second metastasis appeared within 6
months of operation regardless of how long the patients
waited before operation.9
The theoretical argument against delaying resection is
that it decreases the time during which the known metastases
can spawn new metastases. The support for the argument that
pulmonary metastases can indeed lead to further metastatic
spread comes from the observation that approximately 15 to
20% of patients with pulmonary metastases have hilar or
mediastinal nodal involvement.10–17 Thus, there is more sup-
port for the speculative argument against a delay then for a
period of observation.
The 5-year survival has been retrospectively examined
relative to a diagnostic delay period in two studies.9,18 The
first study found no difference in 5-year survival among
several groups of patients with an interval between diagnosis
and resection ranging from 2 weeks to 3 months (Fig-
ure 2).9 The other study found better survival (p  0.05) in
the patients with metastatic colorectal carcinoma resected
within 1 month compared with the patients who underwent
resection more than 1 month after isolated pulmonary metas-
tases were first detected.18
Therefore, although the data are limited, there seems to
be no obvious benefit to delaying resection once a metastasis
has been discovered. We suggest proceeding with metasta-
sectomy as soon as the patient evaluation is completed, based
on well-designed comparative series that directly address the
question.
Should a PET Scan be Performed Before
Metastasectomy to Diagnose Extrathoracic or
Intrathoracic Metastases?
Limited data suggest that PET scanning may be useful
to detect unsuspected extrathoracic metastases before pulmo-
nary metastasectomy with curative intent. The data come
from two retrospective studies, which found that unsuspected
metastases were detected in 9 to 15% of patients.16,19 One of
these studies involved 86 patients in whom extrathoracic
disease was found in 15%, mediastinal disease in 2%, only
benign pulmonary disease in 4%, and a false-positive PET in
extrathoracic sites of 8%.16 The data from the second study
are poorly defined (i.e., criteria defining patients who under-
went PET scanning, whether PET findings were confirmed
etc.) and did not report data in the article but alluded in the
verbal discussion to find extrapulmonary metastases in 9% of
patients with melanoma.19 This study primarily evaluated
survival to see whether PET allowed better selection of
patients for curative therapy. The survival curves cross at
several points and are not visually different, although statis-
tically a trend favoring PET (p  0.06) was found. Further-
more, firm conclusions from this study are prevented by
confounding factors (comparison of patients in different time
periods).
An integrated PET-CT may be better than a dedicated
PET reviewed together with CT images, but data defining the
role of PET-CT for patients considered for metastasectomy
are not yet available.
We recommend that PET be performed, if available,
before metastasectomy in asymptomatic patients to rule out
FIGURE 2. Effect of interval between first detection of a
pulmonary metastasis and metastasectomy.
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occult distant metastases (unless the primary tumor is not
typically PET avid). The potential benefits of this policy seem
to far outweigh the risks in most patients. However, the
recommendation is based on limited data involving poorly
defined descriptive series.
There is likely little value in PET imaging of intratho-
racic lesions in patients with suspected or possible pulmonary
metastases. In general, a prior chest radiograph or chest CT
scan is available in patients with a metachronous presentation
of pulmonary lesions. There is little question that a large
(1-cm lesion) new lesion represents a malignant process in
the absence of a presentation suggesting infection (e.g.,
symptoms, rapid development in the setting of neutropenia).
Limited data suggest that PET is not reliable in smaller
lesions.20–24 The sensitivity of PET for lesions of 8 to 10mm
is 78%, and more importantly, the false negative rate is 100%
for lesions 5mm and 41% for lesions 6 to 10 mm, even
using integral PET/CT scans in a study of pulmonary metas-
tases.20 The only study evaluating PET for the identification
of pulmonary metastases found a sensitivity of approximately
30% for nodules 10 mm and 80% for nodules of 10 to 25
mm.25 The false-negative rate could not be calculated from
the data in this study.25 Thus, there seems to be little value in
PET for the detection of additional small lesions except in
unusual circumstances.
Therefore, we recommend against a PET scan for the
purpose of detecting additional pulmonary metastases or for
diagnosis of a pulmonary nodule in a patient suspect of
having pulmonary metastases. This is based on a lack of
benefit, applicable to most patients, and not likely to change
with further research. Although this involves an extrapolation
of indirect data from similar patients, the data are fairly
extensive and consistent.
Given the incidence of nodal involvement in approxi-
mately 20% of patients,17 an argument can be made for PET
to identify suspicious nodes. However, there are no data
defining the utility of this approach. Given that PET is
proving to be less useful in lung cancer for nodal assessment
relative to a microscopic assessment,26 PET cannot be rec-
ommended for the purpose of nodal assessment. Neverthe-
less, if a PET is performed, any suspicious findings should be
biopsied.26
Is Helical CT Imaging Adequate to Avoid
Palpation of the Lung?
Preoperative CT imaging is not sufficiently accurate to
avoid manual lung palpation if the goal is to remove all
detectable disease, despite the increased ability of helical CT
scan to detect pulmonary nodules compared with conven-
tional CT scan. Many studies with helical CT scan (Table 1)
have found that metastases are missed in approximately 25%
of patients (22–35%) and that helical CT scan does not detect
approximately 25% of metastatic deposits (16–46%). In the
majority of these studies, a 5-mm slice thickness was used.
An analysis of high-resolution CT scan with 3-mm slice
thickness found similar results (25% of metastases were
missed).27 In contralateral exploration of patients with uni-
lateral disease, 50% had metastases that were not seen on
imaging.28 Thoracoscopic resection of all lesions seen on
conventional CT scan with subsequent open exploration has
also revealed missed metastases in 29 to 56% of patients.29,30
Thus, if the goal is to resect all detectable disease,
manual palpation is still necessary, and a thoracoscopic
approach without palpation is suboptimal. An alternative
approach can be proposed of resection of only disease that
can be imaged, with careful follow-up and repeat metasta-
sectomy of further metastases that become apparent on sub-
sequent imaging studies. No comparative data exist regarding
the outcomes of such an alternative approach. Therefore, such
an approach is rational, but in the context of a protocol that
specifies the interval for subsequent CT surveillance and
repeat resection (ideally as a part of a prospective study).
The potential risk of allowing nonvisualized metastases
to remain until they have grown sufficiently large is that these
tumor deposits can result in further metastatic spread. Cur-
rently, it is not possible to determine the source of metastases.
However, the finding that lobar or mediastinal nodal metas-
tases occur in approximately 20% of patients argues that
metastatic spread from the pulmonary metastasis can and
TABLE 1. Accuracy of Helical CT Scan in the Detection of Pulmonary Metastases
Study Patients (n) Meta-stases (n)
Slice
Thickness (mm)
Patients with Missed
Metastasis (%)
Metastases Missed
by CT Scan (%)
Margaritoria et al.27 88 173 3–5 — 18
Loehe et al.12 63 — — 19 17
Parsons et al.41 61 146 8 (4–10) 22 46
Cerfolio et al.42a 57 — 5 18 —
Parsons et al.43 41 88 8 22 22
Kayton et al.28b 28 209 5 35 12
Ambrogi et al.44 22 49 5 32 16
Diederich et al.45 13 43 5 — 23
Average 25 22
a Only patients with peripheral lesions 5 cm included.
b Only sarcoma.
CT, computed tomography.
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does, in fact occur, as opposed to spread only from the
primary tumor site.10–17,31
These arguments for palpation are countered by a
retrospective study comparing the survival in patients with
unilateral disease who underwent a unilateral versus a bilat-
eral approach. This study did not demonstrate a survival
difference.32 Others have corroborated this.33
Finally, as noted earlier, technology is continually ad-
vancing. It is possible that multidetector scanners and ad-
vanced reviewing techniques will change the recommenda-
tion, but as yet there are no data addressing this speculation.
In summary, we find that the data support a weak
recommendation for manual lung palpation, as opposed to
reliance on imaging alone. The data from multiple well-
designed nonrandomized studies consistently show that the
nodules are missed without palpation, but data regarding the
impact on survival are lacking. An alternative approach,
based on speculation of similar outcomes, of reliance on
imaging only can be supported in the context of careful,
defined follow-up and repeat resection when new nodules are
discovered.
What Interval of Follow-Up CT Scans is
Necessary?
No controlled studies are available to define the optimal
imaging protocol after metastasectomy. Data from multiple
case series demonstrate that pulmonary recurrences (new
lesions) are seen in approximately 50 to 60% of patients after
metastasectomy.8 Furthermore, the survival of those (se-
lected) patients who undergo a second or third metastasec-
tomy is quite good, as demonstrated consistently by multiple
studies.8,9,33–40 Those patients undergoing multiple opera-
tions are surely a more selected group, and no information is
available to define how often a second or third matastasec-
tomy was able to be carried out when a recurrence is noted.
However, the data do argue that at least in some cases, there
may be value in careful follow-up after metastasectomy. This
is a weak recommendation, based on benefit that outweighs
harm and applicable to most patients. However, it is based on
only indirect data from uncontrolled observational studies.
Furthermore, the data regarding survival do not prove that
the intervention of repeat metastasectomy was beneficial (the
survival may be merely a reflection of the biology of the
disease in that particular patient).
It seems reasonable to perform a new baseline CT scan
in the postoperative period before new nodules have had a
chance to appear, but after postoperative changes have re-
solved. A CT scan done within several months postopera-
tively is suggested to accomplish this goal. The interval to
performance of subsequent scans after a standard complete
metastasectomy with lung palpation has also not been de-
fined. Although adjustments can be made resulting from an
estimated doubling time (based on prior observation or on the
disease-free interval), a follow-up CT scan every 6 months
for 2 years and then yearly for at least 5 years from the
metastasectomy is proposed as a reasonable starting point.
This proposal is based on speculation and consensus opinion
rather than data, however.
Patients who undergo resection of only those lesions
that can be appreciated by imaging studies (without lung
palpation) should be followed as a part of a prospectively
designed protocol. In the absence of such a study, a shortened
interval of surveillance of helical CT scan every 3 months for
at least a year is proposed. However, this proposal is based on
speculation and consensus opinion rather than data.
CONCLUSION
The assumption is made that metastasectomy is bene-
ficial in appropriately selected patients and that the goal of
metastasectomy is to render the patient disease free. In this
context, technical management questions regarding imaging
can be addressed. The data are limited and often indirect (not
focused specifically on the issue under consideration). Nev-
ertheless, a systematic literature reviews allows some recom-
mendations, suggestions, and proposals to be made.
At a minimum, a helical chest CT scan with a 3- to
5-mm slice thickness (reconstruction interval) is recom-
mended, but where available multislice thin section volumet-
ric scanning and image reconstruction may be better. It is
suggested that in general, a CT scan should be performed
within 4 weeks of metastasectomy, unless tumor doubling
time is short or long. Metastasectomy is suggested once the
evaluation is complete, without a period of observation and
repeat scanning preoperatively. A PET scan, if available, is
recommended in patients suspected of harboring pulmonary
metastases to rule out occult extrapulmonary metastases, but
it is generally not of value in evaluation of the pulmonary
nodules. Palpation of the lungs is recommended to detect
additional metastases beyond what is noted by helical CT
scan (found in approximately 25% of patients), unless a
defined protocol for rescanning and reresection is imple-
mented. Even if palpation at the time of metastasectomy was
done, regular follow-up is recommended based on the limited
indirect data. The interval for follow-up imaging is not
defined, but it is proposed that a baseline scan be obtained 4
to 6 weeks after metastasectomy, with further chest CT scans
every 6 months for 2 years and then yearly. More frequent
follow-up scanning is proposed if the tumor doubling time is
short or if lung palpation was not performed.
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